imciromab pentetate
Trade name: myoscint
mAbapprovedImaging agent
Approved
Jul 3, 1996
Indium (111In) imciromab is a mouse monoclonal antibody labelled with the radioisotope Indium-111. It was used for cardiac imaging, but withdrawn in 1993. — Wikipedia
Clinical trial activity
0 trials · 0 clinical orgs · 1 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
Indications
Approved for
Mechanism of action
- Myosin-2INHIBITOR
MYH2 inhibitor
- Unspecified targetOTHER
Diagnostic (monoclonal antibody that is labelled with Indium (111In) for imaging)
Approval history
- approvedJul 3, 1996
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Discontinued
- Multi-specific
- No
- Imaging
- 111-Indium
Oral
No
Parenteral
Yes
Topical
No
Sources
- WikipediaIndium (111In) imciromab ↗
- NCATS3U979E1001 ↗
- ChEMBLCHEMBL2109289 ↗
- ChEMBLCHEMBL2109038 ↗
Also known as
- (111)indium-labeled antimyosin antibody
- c-4
- c-4
- imciromab
- imciromab (111in)
- imciromab in111
- imciromab pentetate
- imciromab pentetate
- imciromab pentetate
- imciromab pentetate
- imciromab pentetate, radiolabeled product
- indio-111-antiomiosina
- indium-111-antimyosin
- indium-111-antimyosin fab
- indium (111in) imciromab
- indium (111in) imciromab pentetate
- indium antimyosin
- indium in 111 imciromab pentetate
- indium in 111 imciromab pentetate
- indium in-111 imciromab pentetate
- indium in-111 myoscint
- myoscint
- myoscint
- myoscint
- myoscint indium in-111
- r1d10